Federal Register / Vol. 81, No. 29 / Friday, February 12, 2016 / Notices 7551 

as amended. The contract proposals and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the contract 

proposals, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute on 

Drug Abuse Special Emphasis Panel; 

Standardized Rechargeable Electronic 

Nicotine Delivery System (8921). 

Date: March 15, 2016. 

Time: 10:00 a.m. to 11:30 a.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: National Institutes of Health, 

Neuroscience Center, 6001 Executive 

Boulevard, Rockville, MD 20852 (Telephone 

Conference Call). 

Contact Person: Lyle Furr, Scientific 

Review Officer, Office of Extramural Affairs, 

National Institute on Drug Abuse, NIH, 

DHHS, Room 4227, MSC 9550, 6001 

Executive Boulevard, Bethesda, MD 20892– 

9550, (301) 435–1439, lf33c.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program No.: 93.279, Drug Abuse and 

Addiction Research Programs, National 

Institutes of Health, HHS) 

Dated: February 8, 2016. 

Natasha M. Copeland, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2016–02848 Filed 2–11–16; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Drug Abuse; 

Notice of Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute on 

Drug Abuse Special Emphasis Panel, NIH 

Pathway to Independence Award (K99/R00). 

Date: March 2, 2016. 

Time: 9:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hilton Washington/Rockville, 1750 

Rockville Pike, Rockville, MD 20852. 

Contact Person: Susan O. McGuire, Ph.D., 

Scientific Review Officer, Office of 

Extramural Affairs, National Institute on 

Drug Abuse, National Institutes of Health, 

DHHS, 6001 Executive Blvd., Room 4245, 

Rockville, MD 20852, 301–435–1426, 

mcguireso@mail.nih.gov. 

Name of Committee: National Institute on 

Drug Abuse Special Emphasis Panel, 

Identification of Genetic and Genomic 

Variants by Next-Gen Sequencing in Nonhuman Animal Models (U01). 

Date: March 2, 2016. 

Time: 12:00 p.m. to 1:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Neuroscience Center, 6001 Executive 

Boulevard, Rockville, MD 20852, (Telephone 

Conference Call). 

Contact Person: Jose F. Ruiz, Ph.D., 

Scientific Review Officer, Office of 

Extramural Affairs, National Institute on 

Drug Abuse, NIH, Room 4228, MSC 9550, 

6001 Executive Blvd., Bethesda, MD 20892– 

9550, (301) 451–3086, ruizjf@nida.nih.gov. 

Name of Committee: National Institute on 

Drug Abuse Special Emphasis Panel, NIDA 

Translational Avant-Garde Award for 

Development of Medication to Treat 

Substance Use Disorders (UG3/UH3). 

Date: March 4, 2016. 

Time: 8:30 a.m. to 12:30 p.m. 

Agenda: To review and evaluate 

cooperative agreement applications. 

Place: Bethesda North Marriott Hotel & 

Conference Center, 5701 Marinelli Road, 

Bethesda, MD 20852. 

Contact Person: Jose F. Ruiz, Ph.D., 

Scientific Review Officer, Office of 

Extramural Affairs, National Institute on 

Drug Abuse, NIH, Room 4228, MSC 9550, 

6001 Executive Blvd., Bethesda, MD 20892– 

9550, (301) 451–3086, ruizjf@nida.nih.gov. 

Name of Committee: National Institute on 

Drug Abuse Special Emphasis Panel, Phase II 

in person interview: Avenir Award Program 

for Research on Substance Abuse and HIV/ 

AIDS (DP2). 

Date: March 8, 2016. 

Time: 8:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Courtyard by Marriott, 5520 

Wisconsin Avenue, Chevy Chase, MD 20815. 

Contact Person: Hiromi Ono, Ph.D., 

Scientific Review Officer, Office of 

Extramural Affairs, National Institute on 

Drug Abuse, National Institutes of Health, 

DHHS, 6001 Executive Boulevard, Room 

4238, MSC 9550, Bethesda, MD 20892, 301– 

402–6020, hiromi.ono@nih.gov. 

Name of Committee: National Institute on 

Drug Abuse Special Emphasis Panel, Phase II 

in person interview: Avenir Award Program 

for Genetics or Epigenetics of Substance 

Abuse (DP1). 

Date: March 10, 2016. 

Time: 8:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Courtyard by Marriott, 5520 

Wisconsin Avenue, Chevy Chase, MD 20815. 

Contact Person: Hiromi Ono, Ph.D., Scientific 

Review Officer, Office of Extramural Affairs, 

National Institute on Drug Abuse, National 

Institutes of Health, DHHS, 6001 Executive 

Boulevard, Room 4238, MSC 9550, Bethesda, 

MD 20892, 301–402–6020, 

hiromi.ono@nih.gov. 

Name of Committee: National Institute on 

Drug Abuse Special Emphasis Panel, 

Exploratory Studies of Smoking Cessation 

Interventions for People with Schizophrenia 

(R21/R33). 

Date: March 11, 2016. 

Time: 1:00 p.m. to 3:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Neuroscience Center, 6001 Executive 

Boulevard, Rockville, MD 20852, (Telephone 

Conference Call). 

Contact Person: Jose F. Ruiz, Ph.D., 

Scientific Review Officer, Office of 

Extramural Affairs, National Institute on 

Drug Abuse, NIH, Room 4228, MSC 9550, 

6001 Executive Blvd., Bethesda, MD 20892– 

9550, (301) 451–3086, ruizjf@nida.nih.gov. 

Name of Committee: National Institute on 

Drug Abuse Special Emphasis Panel, Loan 

Repayment 2016. 

Date: March 15, 2016. 

Time: 9:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications and/or proposals. 

Place: National Institutes of Health, 

Neuroscience Center, 6001 Executive 

Boulevard, Rockville, MD 20852, (Virtual 

Meeting). 

Contact Person: Lyle Furr, Scientific 

Review Officer, Office of Extramural Policy 

and Review, National Institute on Drug 

Abuse, NIH, DHHS, Room 4227, MSC 9550, 

6001 Executive Boulevard, Bethesda, MD 

20892–9550, (301) 435–1439, lf33c.nih.gov. 

Name of Committee: National Institute on 

Drug Abuse Special Emphasis Panel, NIDA 

Research ‘‘Center of Excellence’’ Grant 

Program (P50). 

Date: March 16, 2016. 

Time: 9:00 a.m. to 4:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Bethesda North Marriott Hotel & 

Conference Center, 5701 Marinelli Road, 

Bethesda, MD 20852. 

Contact Person: Jagadeesh S. Rao, Ph.D., 

Scientific Review Officer, Office of 

Extramural Policy and Review, National 

Institute on Drug Abuse, National Institutes 

of Health, DHHS, 6001 Executive Boulevard, 

Room 4234, MSC 9550, Bethesda, MD 20892, 

301–443–9511, jrao@nida.nih.gov. 

Name of Committee: National Institute on 

Drug Abuse Special Emphasis Panel, NIDA 

Core Center of Excellence Grant Program 

(P30). 

Date: March 17, 2016. 

Time: 9:00 a.m. to 4:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Bethesda North Marriott Hotel & 

Conference Center, 5701 Marinelli Road, 

Bethesda, MD 20852. 

Contact Person: Jagadeesh S. Rao, Ph.D., 

Scientific Review Officer, Office of 

Extramural Policy and Review, National 


asabaliauskas on DSK9F6TC42PROD with NOTICES2
7552 Federal Register / Vol. 81, No. 29 / Friday, February 12, 2016 / Notices 

Institute on Drug Abuse, National Institutes 

of Health, DHHS, 6001 Executive Boulevard, 

Room 4234, MSC 9550, Bethesda, MD 20892, 

301–443–9511, jrao@nida.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos.: 93.279, Drug Abuse and 

Addiction Research Programs, National 

Institutes of Health, HHS) 

Dated: February 8, 2016. 

Natasha M. Copeland, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2016–02849 Filed 2–11–16; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of General Medical 

Sciences; Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: NIGMS Initial Review 

Group; Training and Workforce Development 

Subcommittee—C. 

Date: March 7, 2016. 

Time: 8:30 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Ritz-Carlton Hotel, 1700 Tysons 

Boulevard, McLean, VA 22102. 

Contact Person: Mona R. Trempe, Ph.D., 

Scientific Review Officer, Office of Scientific 

Review, National Institute of General Medical 

Sciences, National Institutes of Health, 45 

Center Drive, Room 3AN12, Bethesda, MD 

20892, 301–594–3998, trempemo@

mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.375, Minority Biomedical 

Research Support; 93.821, Cell Biology and 

Biophysics Research; 93.859, Pharmacology, 

Physiology, and Biological Chemistry 

Research; 93.862, Genetics and 

Developmental Biology Research; 93.88, 

Minority Access to Research Careers; 93.96, 

Special Minority Initiatives; 93.859, 

Biomedical Research and Research Training, 

National Institutes of Health, HHS) 

Dated: February 8, 2016. 

Melanie J. Gray, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2016–02851 Filed 2–11–16; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HOMELAND 

SECURITY 

Coast Guard 

[Docket No. USCG–2016–0017] 

Policy Letter: Guidance for Training of 

Deck Officers on Vessels Subject to 

the International Code for Ships 

Operating in the Polar Waters 

AGENCY: Coast Guard, DHS. 

ACTION: Notice of availability. 

SUMMARY: The Coast Guard announces 

the availability, in the docket, of a 

policy letter which provides voluntary 

guidance for the training of deck officers 

on vessels operating in polar waters. It 

recommends training measures that will 

achieve a higher level of safety for 

mariners working in this specialized 

polar environment. It is applicable to 

SOLAS vessels operating outside the 

boundary line and subject to the 

International Code for Ships Operating 

in Polar Waters (Polar Code). The draft 

policy letter and voluntary guidance 

would not apply to vessels on voyages 

that do not operate in areas subject to 

the Polar Code. 

DATES: This policy letter is effective on 

February 12, 2016. 

FOR FURTHER INFORMATION CONTACT: If 

you have questions about this 

document, contact Cathleen Mauro, 

Marine Personnel Qualifications 

Division (CG–OES–1), U.S. Coast Guard; 

telephone 202–372–1449, or 

Cathleen.B.Mauro@uscg.mil. 

SUPPLEMENTARY INFORMATION: 

Viewing Materials in the Docket 

The policy letter is available in the 

docket and can be viewed by going to 

www.regulations.gov, inserting USCG– 

2016–0017 in the ‘‘Keyword’’ box, and 

then clicking ‘‘Search.’’ 

Background and Purpose 

Current shipping trends show an 

increase in the number of vessels 

regularly transiting remote polar areas. 

Vessels in polar waters experience 

unpredictable and poor weather 

conditions, degraded navigation tools, 

threats to operating equipment and 

increased stability concerns. In response 

to the challenges faced by these vessels 

and the concern for their safe operation, 

the International Maritime Organization 

(IMO) has adopted a mandatory code, 

the International Code for Ships 

Operating in Polar Waters, commonly 

referred to as the Polar Code. The Polar 

Code addresses safety and 

environmental requirements for vessels, 

as well as the level of training required 

for deck officers, and is expected to 

come into force on January 1, 2017. 

In order to obtain input from U.S. 

stakeholders and to facilitate the 

development of the U.S. position at the 

IMO on the training requirements 

needed to support the Polar Code, the 

Merchant Marine Personnel Advisory 

Committee (MERPAC) chartered a 

working group in 2013 to address 

mariner training in support of the polar 

code. The working group developed a 

proposal that included the training 

competencies for U.S. mariners serving 

on ships operating in polar waters. The 

working group held multiple meetings 

and provided recommendations on 

minimum standards of competence, sea 

service, and recency requirements for 

polar training at the basic and advanced 

levels. The group also developed 

recommendations on how existing 

mariners with experience operating in 

polar waters would be grandfathered 

under the new requirements. MERPAC 

adopted the working group’s 

recommendations, which provided the 

basis of the U.S. position regarding the 

relevant amendments to the 

International Convention on Standards 

of Training, Certification and 

Watchkeeping for Seafarers (STCW 

Convention), 1978, as amended, and the 

Seafarers’ Training, Certification and 

Watchkeeping Code (STCW Code). The 

STCW Convention and Code provide 

the international standards for seafarers. 

Through the work of the IMO’s Subcommittee on Human Element, Training 

and Watchkeeping (HTW), amendments 

to the STCW Convention and Code were 

developed to define the training 

requirements needed to support the 

implementation of the Polar Code. 

These amendments were approved by 

the Maritime Safety Committee on its 

Ninety Fifth Session (MSC 95), and are 

expected to be adopted by the IMO in 

July of 2016. The amendments are 

expected to enter into force on January 

1, 2018. 

Cognizant that there is a gap between 

the time the Polar Code enters into force 

on January 1, 2017 and the adoption of 

the amendments to the STCW 

Convention by IMO in July of 2016, the 

Coast Guard has developed a policy 

letter that recommends training 

guidelines for deck officers on vessels 

operating in polar waters. The Coast 

Guard is providing this guidance to 


asabaliauskas on DSK9F6TC42PROD with NOTICES2